Evidence map›Paper›PMID 40327234›Full record

ArticlePhysical and engineering sciences in medicine2025

Feasibility of individual dosimetry using RT-PHITS for patients with SPECT/CT imaging after

Kenta Miwa, Ryo Kakino, Tatsuhiko Sato, Takuya Furuta, Noriaki Miyaji, Tensho Yamao, Kosuke Yamashita, Takashi Terauchi

Abstract read
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Inter-institutional variability in kidney dosimetry duringRadiological physics and technology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kenta Miwa *Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima, 960-8516, Japan. kmiwa@fmu.ac.jp.ORCID http://orcid.org/0000-0003-0802-0180
Ryo Kakino *Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, 569-8686, Japan.
Tatsuhiko SatoNuclear Science and Engineering Center, Japan Atomic Energy Agency, Shirakata 2-4, Tokai, Ibaraki, 319-1195, Japan.
Takuya FurutaNuclear Science and Engineering Center, Japan Atomic Energy Agency, Shirakata 2-4, Tokai, Ibaraki, 319-1195, Japan.
Noriaki MiyajiDepartment of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima, 960-8516, Japan.
Tensho YamaoDepartment of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima, 960-8516, Japan.
Kosuke YamashitaDepartment of Nuclear Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.
Takashi TerauchiDepartment of Nuclear Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A radiotherapy package based on the Particle and Heavy Ion Transport code System (RT-PHITS) can calculate internal 3-dimensional dose distribution from SPECT/CT images of individual patients coupled with Monte Carlo radiation transport simulation. This study aims to determine the feasibility of individual dosimetry using RT-PHITS for patients after

Indexed as

OctreotideOrganometallic CompoundsRadiometryReceptors, PeptideSingle Photon Emission Computed Tomography Computed TomographyFeasibility StudiesHumansMonte Carlo MethodRadiotherapy Dosagelutetium Lu 177 dotatateOctreotideOrganometallic CompoundsReceptors, Peptide177Lu-DOTATATE; PHITSDosimetryMonte Carlo SimulationTargeted Radionuclide Therapy

Identifiers

PMID40327234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.